We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Zyprexa Fines Irrelevant In Actos Trial, Eli Lilly Says

Law360, New York (March 7, 2014, 5:25 PM EST) -- Eli Lilly & Co. argued Thursday that the first federal bellwether trial over the bladder cancer risks of diabetes drug Actos should exclude evidence about its fines for marketing the antipsychotic...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Louisiana Western

Nature of Suit

Personal Inj. Prod. Liability


Subscribers Only

Date Filed

January 17, 2012

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.